Department of Chemical Engineering, University of Washington, Seattle, WA 98195-2180, USA.
J Bacteriol. 2010 Apr;192(7):1813-23. doi: 10.1128/JB.01166-09. Epub 2010 Jan 29.
Methylobacterium extorquens AM1 is a facultative methylotroph capable of growth on both single-carbon and multicarbon compounds. Mutants defective in a pathway involved in converting acetyl-coenzyme A (CoA) to glyoxylate (the ethylmalonyl-CoA pathway) are unable to grow on both C(1) and C(2) compounds, showing that both modes of growth have this pathway in common. However, growth on C(2) compounds via the ethylmalonyl-CoA pathway should require glyoxylate consumption via malate synthase, but a mutant lacking malyl-CoA/beta-methylmalyl-CoA lyase activity (MclA1) that is assumed to be responsible for malate synthase activity still grows on C(2) compounds. Since glyoxylate is toxic to this bacterium, it seemed likely that a system is in place to keep it from accumulating. In this study, we have addressed this question and have shown by microarray analysis, mutant analysis, metabolite measurements, and (13)C-labeling experiments that M. extorquens AM1 contains an additional malyl-CoA/beta-methylmalyl-CoA lyase (MclA2) that appears to take part in glyoxylate metabolism during growth on C(2) compounds. In addition, an alternative pathway appears to be responsible for consuming part of the glyoxylate, converting it to glycine, methylene-H(4)F, and serine. Mutants lacking either pathway have a partial defect for growth on ethylamine, while mutants lacking both pathways are unable to grow appreciably on ethylamine. Our results suggest that the malate synthase reaction is a bottleneck for growth on C(2) compounds by this bacterium, which is partially alleviated by this alternative route for glyoxylate consumption. This strategy of multiple enzymes/pathways for the consumption of a toxic intermediate reflects the metabolic versatility of this facultative methylotroph and is a model for other metabolic networks involving high flux through toxic intermediates.
甲基杆菌(Methylobacterium extorquens AM1)是一种兼性甲基营养菌,能够利用单碳和多碳化合物生长。在涉及将乙酰辅酶 A(CoA)转化为乙醛酸(乙基丙二酰辅酶 A 途径)的途径中发生缺陷的突变体无法在 C(1)和 C(2)化合物上生长,这表明两种生长方式都有这个途径。然而,通过乙基丙二酰辅酶 A 途径在 C(2)化合物上的生长应该需要通过苹果酸合酶消耗乙醛酸,但一个缺乏顺乌头酸酶/β-甲基丙二酰辅酶 A 裂合酶活性(MclA1)的突变体,该酶被认为负责苹果酸合酶活性,仍然可以在 C(2)化合物上生长。由于乙醛酸对这种细菌有毒,因此很可能有一种系统可以防止其积累。在这项研究中,我们通过微阵列分析、突变体分析、代谢物测量和(13)C 标记实验解决了这个问题,并表明甲基杆菌(Methylobacterium extorquens AM1)含有一种额外的顺乌头酸酶/β-甲基丙二酰辅酶 A 裂合酶(MclA2),该酶在利用 C(2)化合物生长时似乎参与了乙醛酸代谢。此外,似乎有一种替代途径负责消耗部分乙醛酸,将其转化为甘氨酸、亚甲基-H(4)F 和丝氨酸。缺乏任何一种途径的突变体在乙基胺上的生长有部分缺陷,而缺乏两种途径的突变体则无法在乙基胺上显著生长。我们的结果表明,苹果酸合酶反应是该细菌利用 C(2)化合物生长的一个瓶颈,通过这种替代途径消耗乙醛酸可以部分缓解。这种针对有毒中间产物的多种酶/途径的策略反映了这种兼性甲基营养菌的代谢多功能性,是涉及高通量有毒中间产物的其他代谢网络的模型。